Blogs about: Genzyme
Featured Blog
Impactiviti Daily 112009
TODAY’S NEWS So, have we been pursuing the wrong course for GERD all this time? Is it actually caused by immune system cells, not stomach acid? Maybe cheap/old/tried-and-true really is better. Diureti… more →
Impactiviti blog
A Crossroads for Biotech Company Genzyme Corp., Recent FDA 483 Places Pressure on Firm to Correct Quality Systems Management, SOPs and CAPAs
PharmaLogika wrote 2 weeks ago: Evan Scullin, MD Genzyme Corporation was founded in 1981 in Cambridge Massachusetts with a focus on … more →
Impactiviti Daily 112009
Steve Woodruff wrote 4 weeks ago: TODAY’S NEWS So, have we been pursuing the wrong course for GERD all this time? Is it actually cause … more →
The Weekly Real Report November 19th
therealreporter wrote 4 weeks ago: Beal Appeal BOSTON—The stars of commercial real estate were out in force Tuesday night for the NAIOP … more →
Genzyme Corporation and to-BBB partner to develop drugs to penetrate brain barrier
silico wrote 1 month ago: The Dutch biotechnology company to-BBB and the American biotechnology company Genzyme Corporation an … more →
Trash drug staying on the market
Leila Darabi wrote 1 month ago: WTF? … more →
The Effusive CEO
Mike Hart wrote 1 month ago: When I read Luke Timmerman’s interview this morning with ISIS CEO Stanley Crooke my immediate … more →
Genzyme shares trade lower on failure of partnered drug
silico wrote 3 months ago: Shares of Genzyme traded lower after a drug it is codeveloping failed in two late-stage clinical tri … more →
Impactiviti Daily 090109
Steve Woodruff wrote 3 months ago: TODAY’S NEWS Combo pills for high cholesterol: no better than higher doses of single drug? Interesti … more →
Impactiviti Daily 082809
Steve Woodruff wrote 3 months ago: TODAY’S NEWS Takeda to move forward with new alogliptin study – Takeda Pharmaceutical Co says … more →
Today's Pharma News 081709
Steve Woodruff wrote 4 months ago: Novartis gets FDA approval for MS drug Extavia. Extavia is essentially re-branded Betaseron, and mar … more →
Why I (still) like Genzyme
Shailesh wrote 4 months ago: Recently, Genzyme has been in the news quite a bit lately because of the viral contamination problem … more →
Public private partnerships in the pharmaceutical sector
silico wrote 5 months ago: In recent years public private partnerships have become an increasingly familiar part of the pharmac … more →
Information wants to be expensive
Arhopala Bazaloides wrote 5 months ago: A snippet from Malcolm Gladwell’s review of Chris Anderson’s book “Free” in … more →
Successful TSB High Value Manufacturing Grant Award
— 1 comment
sapienprocesstechnologies wrote 6 months ago: Sapien Process Technologies works with Brunel University, Dynamic Extractions and GSK for successful … more →
Crazy times...
curlygirl65 wrote 7 months ago: Last week was a hard, weird week. I found out that less than 80% of my division are being picked up … more →
Today's Top Three in Pharma 040209
Steve Woodruff wrote 8 months ago: Solvay shopping its drug business. Belgian conglomerate Solvay is eying an exit of the drug business … more →
Bayer transfers cancer drugs to Genzyme
silico wrote 8 months ago: PharmExec reports that Bayer has entered into a strategic agreement to transfer some of its cancer d … more →
Wednesday Brain Dump: Deal-O-Rama Edition
— 1 comment
Jeremy G wrote 8 months ago: There’s still plenty of deal activity in the pharma and biotech sector this week, even outside … more →
Snapshot: Environmental League of Massachusetts Corporate Council meeting with Governor Patrick
bgrossman wrote 8 months ago: As a member of the Environmental League of Massachusetts Corporate Council, I had the privilege of p … more →
